PURPOSE: To develop a physiologic model contrast medium enhancement by
incorporating available physiologic data and contrast medium pharmaco
kinetics and to predict organ-specific contrast medium enhancement at
computed tomography (CT) with various contrast medium injection protoc
ols in patients of variable height and weight. MATERIALS AND METHODS:
A computer-based, compartmental model of the cardiovascular system was
generated by using human physiologic parameters and more than 100 dif
ferential equations to describe the transport of contrast medium. Bloo
d volume, extracellular fluid volume, and regional blood flow were est
imated from available data. Local structures were modeled mathematical
ly to describe the distribution and dispersion of intravascularly admi
nistered iodinated contrast medium. A global model was formed by integ
rating regional circulation parameters with the models of local struct
ures. Aortic and hepatic CT contrast-enhancement curves were simulated
for three protocols and were compared with mean enhancement curves in
three groups of 25-28 patients (80 patients total; 28 in one group, 2
5 in one group, and 27 in one group) receiving the same protocols. The
percent difference in maximum enhancement between the simulated and e
mpiric curves and the enhancement difference index (sum of the area di
fference between the simulated and empiric curves divided by the total
area under the empiric curve) were computed. RESULTS: The simulated a
nd empiric enhancement-curves closely agreed in maximum enhancement (t
he mean percent difference in the aorta was 7.4%; liver, 4.8%) and in
variation over time (mean enhancement difference index in the aorta wa
s 11.6%; liver, 12.7%). CONCLUSION: A computer-based, physiologic mode
l that may help predict organ-specific CT contrast medium enhancement
for different injection protocols was developed. Such a physiologic mo
del may have many clinical applications.